118 related articles for article (PubMed ID: 21253722)
1. Short-term evaluation of liver tumors after transarterial chemoembolization: limitations and feasibility of contrast-enhanced ultrasonography.
Moschouris H; Malagari K; Papadaki MG; Kornezos I; Gkoutzios P; Tepelenis N; Matsaidonis D
Abdom Imaging; 2011 Dec; 36(6):718-28. PubMed ID: 21253722
[TBL] [Abstract][Full Text] [Related]
2. Unenhanced and contrast-enhanced ultrasonography during hepatic transarterial embolization and chemoembolization with drug-eluting beads.
Moschouris H; Malagari K; Kornezos I; Papadaki MG; Gkoutzios P; Matsaidonis D
Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1215-22. PubMed ID: 20556386
[TBL] [Abstract][Full Text] [Related]
3. Imaging of intrahepatic progression of hepatocellular carcinoma post transarterial chemoembolization. A long-term, prospective evaluation of contrast-enhanced ultrasonography (CEUS).
Moschouris H; Kalokairinou-Motogna M; Vrakas S; Papadatou A; Karagiannis E; Kiltenis M; Kladis-Kalentzis K; Marmaridou K; Papadogeorgopoulos N; Malagari K
Med Ultrason; 2017 Apr; 19(2):134-142. PubMed ID: 28440346
[TBL] [Abstract][Full Text] [Related]
4. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
[TBL] [Abstract][Full Text] [Related]
5. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience.
Moschouris H; Malagari K; Kalokairinou M; Stamatiou K; Marinis A; Papadaki MG
Med Ultrason; 2011 Dec; 13(4):296-301. PubMed ID: 22132402
[TBL] [Abstract][Full Text] [Related]
7. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis.
Moschouris H; Malagari K; Papadaki MG; Kornezos I; Matsaidonis D
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1022-7. PubMed ID: 20101403
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
[TBL] [Abstract][Full Text] [Related]
10. Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.
Wiggermann P; Wohlgemuth WA; Heibl M; Vasilj A; Loss M; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2013; 53(4):337-48. PubMed ID: 22555335
[TBL] [Abstract][Full Text] [Related]
11. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
12. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis.
Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R
J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
[TBL] [Abstract][Full Text] [Related]
15. Contrast enhanced ultrasonography in assessing the treatment response to transarterial chemoembolization in patients with hepatocellular carcinoma.
Sparchez Z; Mocan T; Radu P; Anton O; Bolog N
Med Ultrason; 2016 Mar; 18(1):96-102. PubMed ID: 26962561
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST.
Liu M; Lin MX; Lu MD; Xu ZF; Zheng KG; Wang W; Kuang M; Zhuang WQ; Xie XY
Eur Radiol; 2015 Aug; 25(8):2502-11. PubMed ID: 25702094
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series.
Lekht I; Nayyar M; Luu B; Guichet PL; Ho J; Ter-Oganesyan R; Katz M; Gulati M
Abdom Radiol (NY); 2017 May; 42(5):1400-1407. PubMed ID: 28008454
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results.
Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382
[TBL] [Abstract][Full Text] [Related]
20. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
Liu D; Liu F; Xie X; Su L; Liu M; Xie X; Kuang M; Huang G; Wang Y; Zhou H; Wang K; Lin M; Tian J
Eur Radiol; 2020 Apr; 30(4):2365-2376. PubMed ID: 31900703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
